Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

Cancer charity sees success re-prioritizing industry's shelved compounds

Nature Reviews Drug Discovery volume 13, pages 319–321 (2014)Cite this article

Subjects

Cancer Research UK launched a bold scheme in 2006 to give second chances to industry's de-prioritized compounds. Its first two projects have now run their course, with varying degrees of success.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Asher Mullard
    View author publications

    You can also search for this author in PubMed Google Scholar

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mullard, A. Cancer charity sees success re-prioritizing industry's shelved compounds. Nat Rev Drug Discov 13, 319–321 (2014). https://doi.org/10.1038/nrd4315

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4315

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing